Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Advances in Clinical Chemistry|May 26, 2024
Pleiotropic functions and clinical importance of circulating HDL-PON1 complexAbdolkarim Mahrooz
Diabetes Research and Clinical Practice|February 9, 2026
Insights to HDL dysfunctionality: hypothesis of exhausted HDLAbdolkarim Mahrooz
Current Clinical Pharmacology|September 17, 2016
Pharmacological Interactions of Paraoxonase 1 (PON1): A HDL-Bound Antiatherogenic EnzymeAbdolkarim Mahrooz
Current Opinion in Lipidology|June 4, 2020
Epigenetics of paraoxonasesAbdolkarim Mahrooz, Mike Mackness
Journal of the Neurological Sciences|January 18, 2014
The salt stimulation property of serum paraoxonase (PON1) could be a valuable factor in evaluating the enzyme status in ischemic stroke: the role of activity-determined PON1 192Q/R phenotypesAbdolkarim Mahrooz, Ahad Alizadeh, Ghorban Gohari
Journal of Clinical Laboratory Analysis|November 17, 2011
Naringenin is an inhibitor of human serum paraoxonase (PON1): an in vitro studyAbdolkarim Mahrooz, Mohammad-Reza Rashidi, Mohammad Nouri
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 3, 2021
Epigenetic alterations and genetic variations of angiotensin-converting enzyme 2 (ACE2) as a functional receptor for SARS-CoV-2: potential clinical implicationsAnvarsadat Kianmehr, Isabella Faraoni, Omer Kucuk, et al.
Journal of Research in Medical Sciences : the Official Journal of Isfahan University of Medical Sciences|January 30, 2019
Paraoxonase-2 variants potentially influence insulin resistance, beta-cell function, and their interrelationships with alanine aminotransferase in type 2 diabetesDurdi Qujeq, Abdolkarim Mahrooz, Ahad Alizadeh, et al.
Journal of Diabetes and Metabolic Disorders|November 29, 2024
Unraveling the understudied influence of a lead variant in the 9p21 locus on the atherogenic index among type 2 diabetes patients with coronary artery diseaseMahsa Naserian, Ahad Alizadeh, Mani Nosrati, et al.
Endocrine|April 22, 2021
The complex combination of COVID-19 and diabetes: pleiotropic changes in glucose metabolismAbdolkarim Mahrooz, Giovanna Muscogiuri, Raffaella Buzzetti, et al.
Pageof 5